Full Press Release Details
ALAMEDA, Calif.,July 30, 2025/PRNewswire/ -- Penumbra, Inc. (NYSE:PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 45thAnnual Growth Conference onTuesday, August 12, 2025.
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website atwww.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About PenumbraPenumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visitwww.penumbrainc.comand connect onInstagram,LinkedInandX.
Investor RelationsPenumbra, Inc.[email protected]
SOURCE Penumbra, Inc.
| Event: | Canaccord Genuity 45thAnnual Growth Conference |
| Date: | Tuesday, August 12, 2025 |
| Time: | 12:30pm ET/9:30am PT |